This is a table of adjective/noun combinations and their frequencies from sentences in your study carrel. Use it to search & browse the list to learn more about your study carrel.
| adjective | noun | frequency |
|---|---|---|
| - | cov-2 | 3275 |
| novel | coronavirus | 1004 |
| - | cov | 920 |
| respiratory | syndrome | 574 |
| covid-19 | patients | 528 |
| covid-19 | infection | 191 |
| covid-19 | cases | 124 |
| new | coronavirus | 114 |
| human | transmission | 101 |
| severe | cases | 93 |
| covid-19 | outbreak | 91 |
| severe | disease | 85 |
| infected | patients | 81 |
| - | risk | 80 |
| asymptomatic | patients | 75 |
| respiratory | disease | 69 |
| viral | infection | 67 |
| higher | risk | 63 |
| viral | infections | 60 |
| respiratory | symptoms | 59 |
| human | coronavirus | 58 |
| high | risk | 58 |
| covid-19 | pneumonia | 58 |
| respiratory | infections | 56 |
| first | case | 55 |
| clinical | symptoms | 53 |
| - | cell | 51 |
| - | coronavirus | 49 |
| severe | covid-19 | 47 |
| respiratory | infection | 44 |
| common | symptoms | 43 |
| severe | pneumonia | 43 |
| clinical | studies | 42 |
| - | sars | 38 |
| asymptomatic | cases | 35 |
| new | cases | 34 |
| viral | pneumonia | 32 |
| severe | coronavirus | 31 |
| asymptomatic | infection | 30 |
| respiratory | diseases | 29 |
| respiratory | viruses | 29 |
| asymptomatic | infections | 28 |
| several | studies | 28 |
| severe | patients | 27 |
| clinical | cases | 26 |
| early | transmission | 26 |
| covid-19 | disease | 26 |
| severe | infection | 25 |
| clinical | study | 23 |
| - | china | 23 |
| - | infection | 22 |
| first | cases | 21 |
| human | cells | 21 |
| covid-19 | symptoms | 21 |
| covid-19 | patient | 21 |
| antiviral | treatment | 20 |
| covid-19 | transmission | 19 |
| novel | virus | 19 |
| viral | transmission | 19 |
| asymptomatic | sars | 16 |
| asymptomatic | transmission | 16 |
| immune | cells | 16 |
| novel | sars | 16 |
| potential | treatment | 15 |
| severe | symptoms | 15 |
| new | virus | 15 |
| other | viruses | 14 |
| severe | sars | 14 |
| covid-19 | infections | 14 |
| new | disease | 13 |
| positive | cases | 13 |
| positive | patients | 13 |
| specific | treatment | 13 |
| viral | diseases | 13 |
| human | infection | 12 |
| respiratory | virus | 12 |
| human | sars | 12 |
| first | day | 12 |
| covid-19 | outbreaks | 12 |
| - | case | 12 |
| first | covid-19 | 11 |
| first | patient | 11 |
| human | cell | 11 |
| other | patients | 11 |
| other | symptoms | 11 |
| more | cases | 10 |
| such | patients | 10 |
| low | risk | 10 |
| medical | treatment | 10 |
| infected | cases | 10 |
| highest | risk | 9 |
| several | cases | 9 |
| potential | risk | 9 |
| novel | viruses | 9 |
| human | cases | 9 |
| other | studies | 9 |
| covid-19 | treatment | 9 |
| common | symptom | 9 |
| antiviral | treatments | 9 |
| - | virus | 9 |
| - | patient | 9 |
| asymptomatic | covid-19 | 8 |
| human | infections | 8 |
| new | infections | 8 |
| several | days | 8 |
| severe | infections | 8 |
| other | infections | 7 |
| respiratory | coronavirus | 7 |
| potential | transmission | 7 |
| lower | risk | 7 |
| other | diseases | 7 |
| more | studies | 7 |
| early | outbreak | 7 |
| asymptomatic | disease | 6 |
| early | disease | 6 |
| early | treatment | 6 |
| other | treatment | 6 |
| potential | treatments | 6 |
| such | cases | 6 |
| higher | case | 5 |
| severe | diseases | 5 |
| potential | sars | 5 |
| positive | sars | 5 |
| infected | cells | 5 |
| immune | cell | 5 |
| higher | transmission | 5 |
| other | disease | 5 |
| first | symptom | 5 |
| different | studies | 5 |
| - | day | 5 |
| different | sars | 5 |
| clinical | case | 5 |
| - | transmission | 5 |
| first | infection | 5 |
| respiratory | syndromes | 4 |
| novel | pneumonia | 4 |
| other | case | 4 |
| other | outbreaks | 4 |
| several | virus | 4 |
| several | case | 4 |
| several | patients | 4 |
| medical | treatments | 4 |
| severe | case | 4 |
| viral | disease | 4 |
| more | patients | 4 |
| novel | wuhan | 4 |
| infected | pneumonia | 4 |
| clinical | disease | 4 |
| infected | patient | 4 |
| - | patients | 4 |
| - | pneumonia | 4 |
| asymptomatic | patient | 4 |
| acute | pneumonia | 4 |
| covid-19 | case | 4 |
| first | symptoms | 4 |
| higher | infection | 4 |
| human | cov | 4 |
| important | risk | 4 |
| other | treatments | 3 |
| novel | disease | 3 |
| novel | diseases | 3 |
| other | cases | 3 |
| other | risk | 3 |
| other | sars | 3 |
| viral | de | 3 |
| positive | covid-19 | 3 |
| new | patients | 3 |
| potential | patients | 3 |
| specific | cell | 3 |
| specific | patient | 3 |
| viral | y | 3 |
| new | treatment | 3 |
| potential | infection | 3 |
| new | outbreaks | 3 |
| earlier | studies | 3 |
| new | infection | 3 |
| - | infections | 3 |
| acute | infection | 3 |
| clinical | treatment | 3 |
| different | days | 3 |
| different | study | 3 |
| clinical | symptom | 3 |
| early | cases | 3 |
| early | studies | 3 |
| first | coronavirus | 3 |
| high | case | 3 |
| high | transmission | 3 |
| lower | case | 3 |
| potential | risks | 2 |
| human | studies | 2 |
| immune | studies | 2 |
| infected | cell | 2 |
| new | covid-19 | 2 |
| new | diseases | 2 |
| new | treatments | 2 |
| novel | treatment | 2 |
| other | coronavirus | 2 |
| other | virus | 2 |
| such | disease | 2 |
| respiratory | transmission | 2 |
| respiratory | treatments | 2 |
| several | cell | 2 |
| several | covid-19 | 2 |
| several | viruses | 2 |
| specific | cases | 2 |
| specific | symptoms | 2 |
| human | diseases | 2 |
| such | infections | 2 |
| such | symptoms | 2 |
| human | patients | 2 |
| new | viruses | 2 |
| human | case | 2 |
| different | case | 2 |
| high | infection | 2 |
| - | cells | 2 |
| - | covid-19 | 2 |
| - | outbreak | 2 |
| - | symptom | 2 |
| asymptomatic | case | 2 |
| available | case | 2 |
| clinical | pneumonia | 2 |
| clinical | risk | 2 |
| covid-19 | treatments | 2 |
| - | treatment | 2 |
| different | covid-19 | 2 |
| different | viruses | 2 |
| earlier | study | 2 |
| early | sars | 2 |
| first | days | 2 |
| first | sars | 2 |
| first | studies | 2 |
| different | disease | 2 |
| first | study | 2 |
| novel | cov | 1 |
| new | sars | 1 |
| new | studies | 1 |
| new | symptoms | 1 |
| new | transmissions | 1 |
| novel | case | 1 |
| other | covid-19 | 1 |
| novel | risk | 1 |
| novel | treatments | 1 |
| other | cells | 1 |
| other | patient | 1 |
| more | virus | 1 |
| other | study | 1 |
| new | outbreak | 1 |
| important | coronavirus | 1 |
| more | symptoms | 1 |
| more | sars | 1 |
| more | risk | 1 |
| more | disease | 1 |
| medical | risk | 1 |
| lower | infection | 1 |
| low | infection | 1 |
| infected | case | 1 |
| important | treatments | 1 |
| important | transmission | 1 |
| humans | transmission | 1 |
| humans | sars | 1 |
| humans | case | 1 |
| human | transmissions | 1 |
| positive | patient | 1 |
| positive | case | 1 |
| viral | outbreak | 1 |
| positive | symptoms | 1 |
| specific | sars | 1 |
| viral | treatment | 1 |
| viral | outbreaks | 1 |
| human | disease | 1 |
| viral | cell | 1 |
| viral | al | 1 |
| such | viruses | 1 |
| such | treatments | 1 |
| such | risk | 1 |
| such | outbreak | 1 |
| such | diseases | 1 |
| such | covid-19 | 1 |
| such | case | 1 |
| specific | viruses | 1 |
| specific | treatments | 1 |
| specific | disease | 1 |
| potential | coronavirus | 1 |
| specific | covid-19 | 1 |
| severest | cases | 1 |
| severe | treatment | 1 |
| severe | risk | 1 |
| several | symptoms | 1 |
| several | sars | 1 |
| several | pneumonia | 1 |
| several | outbreaks | 1 |
| several | cells | 1 |
| respiratory | treatment | 1 |
| respiratory | patients | 1 |
| respiratory | outbreaks | 1 |
| potential | outbreaks | 1 |
| potential | outbreak | 1 |
| human | study | 1 |
| different | risk | 1 |
| highest | transmission | 1 |
| available | day | 1 |
| covid-19 | symptom | 1 |
| covid-19 | study | 1 |
| covid-19 | risks | 1 |
| covid-19 | risk | 1 |
| covid-19 | diseases | 1 |
| covid-19 | coronavirus | 1 |
| common | viruses | 1 |
| common | covid-19 | 1 |
| common | coronavirus | 1 |
| clinical | treatments | 1 |
| clinical | syndromes | 1 |
| clinical | sars | 1 |
| clinical | infection | 1 |
| available | studies | 1 |
| asymptomatic | virus | 1 |
| highest | infection | 1 |
| asymptomatic | coronavirus | 1 |
| antiviral | de | 1 |
| acute | sars | 1 |
| acute | infections | 1 |
| acute | covid-19 | 1 |
| acute | coronavirus | 1 |
| - | wuhan | 1 |
| - | viruses | 1 |
| - | symptoms | 1 |
| - | study | 1 |
| - | studies | 1 |
| - | disease | 1 |
| - | de | 1 |
| - | cases | 1 |
| covid-19 | virus | 1 |
| different | coronavirus | 1 |
| different | infection | 1 |
| different | outbreaks | 1 |
| higher | sars | 1 |
| higher | risks | 1 |
| higher | cases | 1 |
| high | virus | 1 |
| high | sars | 1 |
| high | risks | 1 |
| first | outbreaks | 1 |
| first | outbreak | 1 |
| early | wuhan | 1 |
| early | virus | 1 |
| early | study | 1 |
| early | risk | 1 |
| early | patients | 1 |
| early | patient | 1 |
| early | outbreaks | 1 |
| early | infection | 1 |
| early | days | 1 |
| early | covid-19 | 1 |
| earliest | study | 1 |
| earliest | case | 1 |
| earlier | treatment | 1 |
| earlier | sars | 1 |
| earlier | outbreaks | 1 |
| earlier | days | 1 |
| earlier | cases | 1 |
| different | virus | 1 |
| different | transmission | 1 |
| different | patients | 1 |
| different | patient | 1 |
| viral | treatments | 1 |